(Q37624721)

21 August 2017

1 reference

title

Anidulafungin, a new echinocandin: effectiveness and tolerability (English)

1 reference

21 August 2017

1 reference

ChEBI release 2020-05-28

Francesco Menichetti

1

1 reference

21 August 2017

publication date

1 January 2009

1 reference

21 August 2017

1 reference

21 August 2017

volume

69 Suppl 1

1 reference

21 August 2017

page(s)

95-97

1 reference

A prospective observational study of candidemia: epidemiology, therapy, and influences on mortality in hospitalized adult and pediatric patients.

21 August 2017

cites work

1 reference

12 December 2020

Results from the ARTEMIS DISK Global Antifungal Surveillance Study: a 6.5-year analysis of susceptibilities of Candida and other yeast species to fluconazole and voriconazole by standardized disk diffusion testing.

1 reference

12 December 2020

Role of sentinel surveillance of candidemia: trends in species distribution and antifungal susceptibility

1 reference

12 December 2020

Phase 2, randomized, dose-ranging study evaluating the safety and efficacy of anidulafungin in invasive candidiasis and candidemia

1 reference

12 December 2020

Incidence of bloodstream infections due to Candida species and in vitro susceptibilities of isolates collected from 1998 to 2000 in a population-based active surveillance program

1 reference

12 December 2020

Increasing incidence of candidemia: results from a 20-year nationwide study in Iceland

1 reference

12 December 2020

Candida glabrata fungemia: experience in a tertiary care center

1 reference

12 December 2020

Anidulafungin versus fluconazole for invasive candidiasis

1 reference

12 December 2020

A randomized, double-blind trial of anidulafungin versus fluconazole for the treatment of esophageal candidiasis

1 reference

12 December 2020

Echinocandin antifungal drugs

1 reference

12 December 2020

Anidulafungin: a novel echinocandin

1 reference

12 December 2020

In vitro susceptibilities of Candida spp. to caspofungin: four years of global surveillance

1 reference

12 December 2020

Seminational surveillance of fungemia in Denmark: notably high rates of fungemia and numbers of isolates with reduced azole susceptibility.

1 reference

12 December 2020

The epidemiology of candidemia in two United States cities: results of a population-based active surveillance

1 reference

12 December 2020

Epidemiology and predictors of mortality in cases of Candida bloodstream infection: results from population-based surveillance, barcelona, Spain, from 2002 to 2003.

1 reference

12 December 2020

Stable susceptibility of Candida blood isolates to fluconazole despite increasing use during the past 10 years

1 reference

12 December 2020

Candidemia in Norway (1991 to 2003): results from a nationwide study

1 reference

12 December 2020

In vitro activities of ravuconazole and voriconazole compared with those of four approved systemic antifungal agents against 6,970 clinical isolates of Candida spp.

1 reference

12 December 2020

Has the epidemiology of nosocomial candidemia changed?

1 reference

12 December 2020

Trends in species causing fungaemia in a tertiary care medical centre over 12 years

1 reference

12 December 2020

Epidemiology of candidemia: 3-year results from the emerging infections and the epidemiology of Iowa organisms study.

1 reference

12 December 2020

10.2165/11315570-000000000-00000

Identifiers

DOI

1 reference

21 August 2017

1 reference